02675 EDGE MEDICAL-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 8.11X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.5% | Net Margin | N/A |
| Total Debt/Equity | 0.8% | Return on Equity | N/A |
| Price/Book | 16.51X | Return on Assets | N/A |
| (HKD 56.800) | 2025-12 | 2024-12 | 2023-12 |
| Net Profit (MHKD) | -98.63 | -232.38 | -234.62 |
|---|---|---|---|
| Net Profit Growth (%) | +57.6 | +1.0 | N/A |
| Earnings Per Share (HKD) | -0.274 | -0.646 | -0.652 |
| Earnings Per Share Growth (%) | +57.6 | +1.0 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | 3.441 | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 455.715 | 159.994 | +184.8 | 48.042 |
| Operating Result | -88.516 | -218.509 | -59.5 | -212.869 |
| Associates | -0.091 | 0 | N/A | 0 |
| Profit Before Taxation | -88.607 | -218.509 | -59.4 | -212.869 |
| Profit /( Loss) After Taxation | -88.607 | -218.509 | -59.4 | -212.869 |
| Net Profit | -88.607 | -218.509 | -59.4 | -212.869 |
| Earnings Per Share () | -0.2740 | -0.6455 | -57.6 | -0.6517 |
| Announcement Date | 2026-03-27 | 2025-12-30 | NA | 2025-12-30 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
